Color & Maven: Cancer, fertility, and the future of women's health

Cancer rates among younger adults are rising, yet fewer than half of patients report having fertility preservation discussed before treatment begins. At the same time, fertility decisions often need to be made within days of diagnosis. For many women and young families, the cancer journey forces life-altering choices about treatment and future family-building under intense time pressure, and in a system where oncology and reproductive care are too often fragmented.

In this webinar, Caroline Savello, President of Color, and Kate Ryder, Founder & CEO of Maven Clinic, will introduce a first-of-its-kind partnership designed to close this critical gap. Together, we’ve built an integrated oncofertility care pathway that embeds fertility preservation directly into oncologist-led cancer care, not as a downstream referral, but as a coordinated, proactive model of care.

Attendees will learn:

• Why oncofertility is a critical, but overlooked component of cancer care and the clinical, emotional, and financial consequences of addressing it too late
• How integrated oncology and fertility support improves outcomes through proactive dual routing, shared clinical interventions, and accelerated access to fertility preservation services
• What this partnership means for employers and consultants, and how, as customers, you can enable modern support for your members

If you want to learn more about Maven, request time with their team here.
If you want to learn more about Color, request time with their team here.